Austin Davis(@Davis_Austi) 's Twitter Profile Photo

Orphan drugs are a lifeline for individuals with rare diseases, providing hope and improved quality of life. Their development and availability have transformed the landscape of healthcare. $LSDI

Orphan drugs are a lifeline for individuals with rare diseases, providing hope and improved quality of life. Their development and availability have transformed the landscape of healthcare. #LucyScientificInc $LSDI #OrphanDrugs #RareDiseases
account_circle
Rare Disease Research Partners(@RD__RP) 's Twitter Profile Photo

It’s day 2 of the where Alex Morrison, Benedicta Marshall-Andrew, and Samantha Wiseman, are using this invaluable opportunity to discuss, network and gain insights into innovative ideas in the fields of and .

It’s day 2 of the #orphandrugcongress where Alex Morrison, Benedicta Marshall-Andrew, and Samantha Wiseman, are using this invaluable opportunity to discuss, network and gain insights into innovative ideas in the fields of #orphandrugs and #rarediseases. #research #clinicaltrials
account_circle
PILA PHARMA(@PilaPharma) 's Twitter Profile Photo

The start of a new week! 🌟
On Wednesday we'll be back in to present Redeye AB's special event!
We'll take the stage at 13:30 CET and elaborate on our project for the !
redeye.se/events/870532/…

The start of a new week! 🌟
On Wednesday we'll be back in #Stockholm to present Redeye AB's special #OrphanDrugs event!
We'll take the stage at 13:30 CET and elaborate on our project for the #raredisease #Erythromelalgia! 
redeye.se/events/870532/…
#PILA #Investment #Lifescience
account_circle
OKYO Pharma LTD(@OkyoPharma) 's Twitter Profile Photo

OKYO Pharma Receives FDA Approval of IND for OK-101 in Neuropathic Corneal Pain (NCP). NCP is a major unmet medical need and listed as an Orphan disease.
$OKYO drugs
okyopharma.com/okyo-pharma-re…

OKYO Pharma Receives FDA Approval of IND for OK-101 in Neuropathic Corneal Pain (NCP). NCP is a major unmet medical need and listed as an Orphan disease.
$OKYO #neuropathiccornealpain #NCP #orphandrugs #orphan
okyopharma.com/okyo-pharma-re…
account_circle
Evaluate Pharma(@evaluatepharma) 's Twitter Profile Photo

Missed our recent ? Fear not.

Review the companies, drugs and therapy areas fuelling growth of the market and the impact of the on orphan drug development.

On-demand version: bit.ly/3ZKCaua

account_circle
Maximilian Blindzellner(@MaxBlindzellner) 's Twitter Profile Photo

Spannende Perspektiven heute auf der 2023.
Mein Beitrag zu :
Zielgerichtetere Förderung und bessere Evidenz sind der Schlüssel für eine nachhaltige Versorgung von Menschen mit mit guten Therapien.

Allianz Chronischer Seltener Erkrankungen e.V.

Spannende Perspektiven heute auf der #NAKSE 2023. 
Mein Beitrag zu #OrphanDrugs:
Zielgerichtetere Förderung und bessere Evidenz sind der Schlüssel für eine nachhaltige Versorgung von Menschen mit #SeltenenErkrankungen mit guten Therapien.

@ACHSEeV
account_circle
Lumanity(@lumanity) 's Twitter Profile Photo

If you are at this week, be sure to connect with Tom Murtagh at the meeting, or reach out to us at [email protected] to learn more about how we can provide guidance in rare disease and gene therapy.

If you are at #WODC2023 this week, be sure to connect with Tom Murtagh at the meeting, or reach out to us at contact@lumanity.com to learn more about how we can provide guidance in rare disease and gene therapy.

#cellandgenetherapy #orphandrugs #WorldOrphanDrugUSA
account_circle
Rallybio(@rallybio) 's Twitter Profile Photo

Today at NORD Summit in Washington D.C., our CEO, Stephen Uden, M.D., joins industry leaders to discuss the present and future of and . Learn more about : nordsummit.org/agenda/

Today at @RareDiseases Summit in Washington D.C., our CEO, Stephen Uden, M.D., joins industry leaders to discuss the present and future of #rarediseases and #orphandrugs. Learn more about #NORDSummit: nordsummit.org/agenda/
account_circle
Lori Dorer(@lori_dorer) 's Twitter Profile Photo

Hear from Rachel Smith, Head of Rare Disease at Parexel, during the World Orphan Drug Congress in Boston this week!
parexel.com/about-us/event… 24

account_circle
Medannex Ltd(@MedannexLtd) 's Twitter Profile Photo

Delighted that MDX-124 has received Medicinal Product positive opinion for driven by data showing inhibition of tumour growth and improved survival, and powerful synergy with standard of care treatments

Delighted that MDX-124 has received #EMA #Orphan Medicinal Product positive opinion for #pancreaticcancer driven by data showing inhibition of tumour growth and improved survival, and powerful synergy with standard of care treatments #rarediseaseday2023 #orphandrugs #oncology
account_circle
Rallybio(@rallybio) 's Twitter Profile Photo

Our Co-Founder & Executive Chairman, Martin Mackay, Ph.D., joins a panel NORD Summit today, 1:40pm ET, discussing orphan product investment now and in the years ahead. Learn more about : nordsummit.org/agenda/

Our Co-Founder & Executive Chairman, Martin Mackay, Ph.D., joins a panel @RareDiseases Summit today, 1:40pm ET, discussing orphan product investment now and in the years ahead. Learn more about #NORDSummit: nordsummit.org/agenda/ #RareDiseases #OrphanDrugs #biotechinvesting
account_circle
SKC Consulting(@consulting_skc) 's Twitter Profile Photo

SKC is excited to announce that we will be attending the World Orphan Drug Congress USA 2024 World Orphan Drug Congress USA, the most important and comprehensive event for the industry. Get more information on eu1.hubs.ly/H08jgJV0

SKC is excited to announce that we will be attending the World Orphan Drug Congress USA 2024 @OrphanConf, the most important and comprehensive event for the #RareDisease industry. Get more information on eu1.hubs.ly/H08jgJV0 #OrphanDrugs #MarketAccess #ATMPs #GeneTherapies
account_circle
Gillian Sapia RN(@GillianHSapia) 's Twitter Profile Photo

My daughter with no treatment options joined a 3 years ago. has changed its requirement many times in the last few years for rare disease making it harder to approval like AT-007. We just found out she was on placebo for 18 months. We now get to…

My daughter with no treatment options joined a #drugtrial 3 years ago. #FDA has changed its requirement many times in the last few years for rare disease making it harder to approval #OrphanDrugs like AT-007. We just found out she was on placebo for 18 months. We now get to…
account_circle
World Orphan Drug Congress(@orphan_drugs) 's Twitter Profile Photo

We are 6 months away from this year's 2024! 💫

This year is set to be our best one yet with over 2000+ attendees, 250+ speakers and 130+ exhibitors!

🎟️Register now to save 70% off on our tickets: buff.ly/3t7msim

account_circle
ChemieBW(@chemie_bw) 's Twitter Profile Photo

Tag der : Betroffene wollen sensibilisieren. Hoffnung gibt: ein Drittel der Medikamente, die in den vergangenen fünf Jahren auf den Markt kamen, sind . vfa Pharma VCI Bild: Canva/Dall-E

Tag der #SeltenenErkrankungen: Betroffene wollen sensibilisieren. Hoffnung gibt: ein Drittel der Medikamente, die in den vergangenen fünf Jahren auf den Markt kamen, sind #OrphanDrugs. @vfapharma @chemieverband #rarediseaseday Bild: Canva/Dall-E
account_circle
MarketPublishers.com(@Market_Reports) 's Twitter Profile Photo

🧬💊 are developed specifically to treat , offering hope and solutions to patients and families often overlooked by mainstream development.

Get access to cutting-edge information on the orphan drugs market at bit.ly/48FfboH

🧬💊 #OrphanDrugs are developed specifically to treat #RareDiseases, offering hope and solutions to patients and families often overlooked by mainstream #pharmaceutical development.

Get access to cutting-edge information on the orphan drugs market at bit.ly/48FfboH
account_circle